UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 42

of 'Clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia'

42
TI
BCR-ABL1 mutation≠ponatinib resistance.
AU
Saglio G, Fava C
SO
Blood. 2016 Feb;127(6):666-7.
 
AD
UNIVERSITY OF TURIN.
PMID